已收盤 02-06 16:00:00 美东时间
+0.233
+0.88%
Infleqtion, formerly ColdQuanta, is an under-the-radar quantum computing and sensing company set to go public in the coming weeks via SPAC merger with well-known Wall Street dealmaker Michael Klein's Churchill Capital Corp X (NASDAQ:CCCX).
02-07 03:18
Chevron's Tengiz problems hurt Kazakhstan's CPC oil exports MOSCOW/LONDON, Feb 6 (Reuters) - Kazakhstan's planned oil exports could fall by as much as 35% this month via its main route through Russia, four trading sources have told Reuters, as the giant Tengiz oilfield slowly recovers from fires at
02-06 21:39
Biogen Q4 results beat; forecasts 2026 adj EPS $15.25-$16.25 Overview Biotechnology firm's Q4 2025 revenue beat analyst expectations Adjusted EPS for Q4 2025 beat analyst expectations Company expects 2026 revenue to decline by mid-single digit percentage Outlook Biogen expects full-year 2026 revenue
02-06 20:05
MDU Resources Q4 revenue misses estimates Overview Energy delivery firm's Q4 revenue missed analyst expectations Company acquired 49% stake in Badger Wind Farm Outlook MDU Resources expects 2026 EPS between $0.93 and $1.00 Company plans $560 mln capital investment in 2026 MDU Resources anticipates l
02-05 21:40
BRIEF-Tinybuild Says Rev Slightly Ahead Of Expectations Resulted In Positive EBITDA For H2 Feb 5 (Reuters) - Tinybuild Inc TBLD.L : TINYBUILD, INC. - PRE-CLOSE TRADING UPDATE TINYBUILD INC: PIPELINE FOR 2026 AND BEYOND IS STRONG TINYBUILD: REVENUE SLIGHTLY AHEAD OF EXPECTATIONS RESULTED IN POSITIVE
02-05 15:28
BRIEF-Generate Biomedicines Inc - Announces Initial Public Offering Feb 4 (Reuters) - GENERATE BIOMEDICINES INC - ANNOUNCES INITIAL PUBLIC OFFERING - SEC FILING GENERATE BIOMEDICINES INC - APPLIES TO LIST ON NASDAQ AS GENB - SEC FILING GENERATE BIOMEDICINES INC - GOLDMAN SACHS & CO,MORGAN STANLEY ,P
02-05 06:59
GRI Bio raises $14.5 mln to fund operations into Q1 2027 Overview Biotechnology company raised $14.5 mln in gross proceeds to fund operations into Q1 2027 Company announced positive Phase 2a data for GRI-0621 in idiopathic pulmonary fibrosis Cash position expected to fund operations into Q1 2027 Out
02-04 21:56
BRIEF-Pfizer’S Ultra-Long-Acting Injectable Glp-1 RA Shows Weight Loss Results In Phase 2B Trial Feb 3 (Reuters) - Pfizer Inc PFE.N : PFIZER’S ULTRA-LONG-ACTING INJECTABLE GLP-1 RA SHOWS ROBUST AND CONTINUED WEIGHT LOSS WITH MONTHLY DOSING IN PHASE 2B TRIAL PFIZER’S ULTRA-LONG-ACTING INJECTABLE GLP-
02-03 21:21
Enterprise Products Q4 revenue beats analyst expectations on record volumes Overview Midstream energy provider's Q4 revenue beat analyst expectations Adjusted EBITDA for Q4 beat analyst expectations Company repurchased $50 mln of common units in Q4 Outlook Enterprise expects organic growth capital i
02-03 19:09
BRIEF-Pharming Group Expects 2026 Revenue At $405-$425 Mln Feb 3 (Reuters) - Pharming Group NV PHAR.AS : ANNOUNCES 2026 FINANCIAL GUIDANCE AND HIGHLIGHTS RARE DISEASE PIPELINE AT INVESTOR DAY 2026 REVENUE GUIDANCE OF $405-$425 MILLION 2026 OPERATING EXPENSE GUIDANCE OF $330-$335 MILLION Source text:
02-03 14:09